Viking Global Investors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386M | Sell |
34,237,779
-11,775,973
| -26% | -$133M | 1.12% | 35 |
|
|
2025
Q1 | $464M | Sell |
46,013,752
-1,796,208
| -4% | -$18.1M | 1.48% | 27 |
|
|
2024
Q4 | $566M | Sell |
47,809,960
-6,289,106
| -12% | -$74.4M | 1.83% | 20 |
|
|
2024
Q3 | $624M | Sell |
54,099,066
-15,056,780
| -22% | -$174M | 2.28% | 17 |
|
|
2024
Q2 | $731M | Sell |
69,155,846
-213,115
| -0.3% | -$2.25M | 2.81% | 12 |
|
|
2024
Q1 | $731M | Hold |
69,368,961
| – | – | 2.72% | 10 |
|
|
2023
Q4 | $779M | Sell |
69,368,961
-4,065,340
| -6% | -$45.7M | 2.85% | 11 |
|
|
2023
Q3 | $858M | Sell |
73,434,301
-1,804,399
| -2% | -$21.1M | 3.48% | 11 |
|
|
2023
Q2 | $758M | Sell |
75,238,700
-13,000,000
| -15% | -$131M | 3.1% | 7 |
|
|
2023
Q1 | $651M | Hold |
88,238,700
| – | – | 3.06% | 13 |
|
|
2022
Q4 | $705M | Hold |
88,238,700
| – | – | 3.53% | 7 |
|
|
2022
Q3 | $284M | Hold |
88,238,700
| – | – | 1.31% | 29 |
|
|
2022
Q2 | $359M | Hold |
88,238,700
| – | – | 1.64% | 25 |
|
|
2022
Q1 | $436M | Hold |
88,238,700
| – | – | 1.76% | 18 |
|
|
2021
Q4 | $889M | Buy |
+88,238,700
| New | +$889M | 2.56% | 9 |
|